This current meta-analysis demonstrates that intake of ACB reduces HbA1c, FPG, and serum insulin by 33%, 3.56 pmol/L, and 6.74 mIU/mL, in patients with T2D, T1D, and IGT populations, respectively. The gene discussed is INS; the disease is type 2 diabetes mellitus.